Brind.

Applied DNA Sciences and BioMarin Pharmaceutical are identified as competing companies within the healthcare market.

2 reports, 1 independent Updated Sep 8

Gone quiet

Reports: 2
Developments: 1
Repetition: 50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Applied DNA Sciences and BioMarin Pharmaceutical are identified as competing companies within the healthcare market.

Who's involved

What this event is mainly about

Applied DNA Sciences BioMarin Pharmaceutical

Keep exploring

The entities involved

Applied DNA Sciences
American high-technology company
- Countermeasures target Applied DNA Sciences' business operations following its involvement in a supply chain from Xinjiang.Fri 12:57
- MarketBeat is reporting on analyst recommendations and consensus target prices for small-cap healthcare companies Myriad Genetics and Applied DNA Sciences.Fri 11:44
BioMarin Pharmaceutical
American company
- Investors are comparing the financial performance metrics of BioMarin Pharmaceutical and Metagenomi.Sun 20:41

Coverage

Newest first; wire copies grouped

Sep 3tickerreport.com

1 more outlet ran the same wire story

Sep 8themarketsdaily.com